Thursday, September 19, 2024
info@businessfast.co.uk
Business Fast
enterprise

Zelgen Biopharmaceuticals Certified as High-Tech Enterprise in China – Marketscreener.com

March 3, 2023
posted on



MT Newswires 2023

All news about SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.

Sales 2021 190 M
27,5 M
27,5 M
Net income 2021 -451 M
-65,2 M
-65,2 M
Net cash 2021 978 M
142 M
142 M
P/E ratio 2021 -31,3x
Yield 2021 –
Capitalization 12 096 M
1 750 M
1 750 M
EV / Sales 2020 505x
EV / Sales 2021 69,0x
Nbr of Employees 688
Free-Float 48,0%

Chart SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.



Duration :


Period :




Suzhou Zelgen Biopharmaceuticals Co., Ltd. Technical Analysis Chart | MarketScreener

Technical analysis trends SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD.

Short Term Mid-Term Long Term
Trends Neutral Bullish Bullish

Income Statement Evolution




READ SOURCE

You Might Also Like

Recommended For You







This website uses cookies. By continuing to use this site, you accept our use of cookies.